European Biotech Acquisition Corp (EBAC) Adds $14M in Financing to Oculis Deal
European Biotech (NASDAQ:EBAC) announced in an 8-K this morning that it has increased its PIPE by $7.8 million and added $7 million to the convertible loans attached to the combination with biotech firm Oculis. ...READ MORE
